OLMA
OLEMA PHARMACEUTICALS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
OLEMA PHARMACEUTICALS INC (OLMA) is held as common stock by 3 tracked hedge-fund managers, with a combined reported value of ~$33.77M; the largest are Steven Cohen, Stanley Druckenmiller, Ken Griffin. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 added, 1 trimmed, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · LowThis quarter · Quiet
Common-stock holders32 also report options
Congress trades0
Price$8.61vs quarter-end-31.18%
Sectors0
This quarter's moves
Top holderNew0
Added1
Trimmed / sold2
Steven CohenCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $12.35M0.3% of portfolio986,8272026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Stanley Druckenmiller | $12.35M | 0.3% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $691.8K— of portfolio55,3002026 Q2
Value $356.5K— of portfolio28,5002026 Q2
Value $252.7K— of portfolio20,2002026 Q2
Value $27.5K— of portfolio2,2002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $691.8K | — | — |
| Ken GriffinPUT | $356.5K | — | — |
| Steven CohenCALL | $252.7K | — | — |
| Steven CohenPUT | $27.5K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.